Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 10,478,614 shares at $21.64 ($229.4M) on 2025-12-11, disclosed to the SEC on 2025-12-15.
Open-market sale of $229.4M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.64 | 774,142 | $16.8M | 7.3% |
| 2 | $21.64 | 774,142 | $16.8M | 7.3% |
| 3 | $21.64 | 1,095,550 | $23.7M | 10.3% |
| 4 | $21.96 | 1,975,858 | $43.4M | 18.9% |
| 5 | $21.96 | 1,975,858 | $43.4M | 18.9% |
| 6 | $21.96 | 2,696,866 |
| $59.2M |
| 25.8% |
| 7 | $22.05 | 353,745 | $7.8M | 3.4% |
| 8 | $22.05 | 353,745 | $7.8M | 3.4% |
| 9 | $22.05 | 478,708 | $10.6M | 4.6% |
| Total | $21.89 avg | 10,478,614 | $229.4M | 100% |
| Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |
| ROIV | SELL | 2025-05-08 | $13.3M | — | Filing → |